-
公开(公告)号：US12232794B2
公开(公告)日：2025-02-25
申请号：US17328972
申请日：2021-05-24
Applicant: Alan N. Schwartz
Inventor： Alan N. Schwartz
IPC: A61B18/06 , A61B17/00 , A61B18/00 , A61B18/02 , A61B18/04 , A61B18/14 , A61B90/00 , A61M25/00 , A61N1/00 , A61N1/40 , A61N2/00 , A61N5/00 , A61N5/10 , A61N7/02
Abstract: A vaginal device is described. A conformable vaginal insert is shaped for insertion into a vaginal cavity of a female human. A contact point is configured to change a shape of the insert. A sensor is configured to measure and to relay characteristics of the vaginal cavity and the surrounding and supportive structures of the vaginal cavity. A processor is configured to control the contact point to adjust the shape of the insert, generate a treatment for the vaginal cavity and the surrounding structures of the vaginal cavity and the supportive structures of the vaginal cavity comprising a vaginal cavity profile generated from the measured characteristics, store the measured characteristics and the vaginal cavity profile, and based on the stored measured characteristics and the stored vaginal cavity profile, automatically modify the shape of the insert by control of the contact point to provide the treatment to the vaginal cavity.
-
公开(公告)号：US20240415563A1
公开(公告)日：2024-12-19
申请号：US18699551
申请日：2022-10-25
Inventor： Gerry Oliver McCaffrey , Cian Walsh , Kelsey Sandquist , Enda Carter , Gerry Broderick
Abstract: An example catheter includes an elongated member configured to be navigated through vasculature of a patient to a target treatment site in a vessel of the patient, a needle positioned at a distal portion of the elongated member, the needle configured to be within the elongated member when in a delivery configuration and radially extended to puncture a vessel wall of the vessel at the target treatment site when in a deployed configuration, and an expandable balloon including a needle guide configured to position a distal end of the needle at a predetermined distance from a central axis of the elongated member when the balloon is in an expanded configuration and the needle is in the deployed configuration.
-
公开(公告)号：US20240407848A1
公开(公告)日：2024-12-12
申请号：US18810253
申请日：2024-08-20
Inventor： Paul J. Coates , Douglas A. Hettrick
IPC: A61B34/10 , A61B5/00 , A61B5/0536 , A61B5/055 , A61B5/20 , A61B6/00 , A61B6/03 , A61B6/12 , A61B6/46 , A61B6/50 , A61B8/00 , A61B8/08 , A61B17/32 , A61B18/00 , A61B18/02 , A61B18/06 , A61B18/14 , A61B18/18 , A61B18/24 , A61B34/00 , A61B34/20 , A61B90/00 , G16H50/50
Abstract: Example systems and techniques for denervation, for example, renal denervation. In some examples, a processor determines one or more tissue characteristics of tissue proximate a target nerve and a blood vessel. The processor may generate, based on the one or more tissue characteristics, an estimated volume of influence of denervation therapy delivered by a therapy delivery device disposed within the blood vessel. The processor may generate a graphical user interface including a graphical representation of the tissue proximate the target nerve and the blood vessel and a graphical representation of the estimated volume of influence.
-
公开(公告)号：US20240407839A1
公开(公告)日：2024-12-12
申请号：US18810732
申请日：2024-08-21
Inventor： Steven C. Christian , Theodore A. Johnson
Abstract: Cardiac ablation devices and systems are disclosed. A system in accordance with the present disclosure comprises an ablation generator, an electronic control unit (ECU), a control system, and a catheter. The catheter comprises at least one ablation electrode, a catheter shaft including a fluid lumen, and a plurality of thermal sensors. The ECU is configured to receive temperature measurement data from the plurality of thermal sensors, determine a power rate delivery value based on the temperature measurement data, and output the power rate delivery value. The control system is configured to receive the power rate delivery value and control energy delivery of the ablation generator based at least in part on the power rate delivery value.
-
公开(公告)号：US20240358963A1
公开(公告)日：2024-10-31
申请号：US18526542
申请日：2023-12-01
Applicant: Fractyl Health, Inc.
Inventor： Harith RAJAGOPALAN , Jay CAPLAN , Craig M. GARDNER , J. Christopher FLAHERTY
IPC: A61M25/00 , A61B5/00 , A61B5/055 , A61B17/00 , A61B17/02 , A61B17/30 , A61B17/34 , A61B18/00 , A61B18/02 , A61B18/04 , A61B18/06 , A61B18/08 , A61B18/14 , A61B18/18 , A61B18/24 , A61B90/00 , A61F5/00 , A61M25/04 , A61N7/00 , A61N7/02
CPC classification number: A61M25/00 , A61B5/0036 , A61B5/0084 , A61B5/4255 , A61B5/4836 , A61B5/6852 , A61B5/6885 , A61B17/00234 , A61B18/02 , A61B18/082 , A61B18/1492 , A61B18/1815 , A61F5/0069 , A61F5/0079 , A61M25/04 , A61N7/00 , A61B5/0066 , A61B5/055 , A61B2017/00004 , A61B2017/00022 , A61B2017/00199 , A61B2017/00269 , A61B17/00491 , A61B2017/00818 , A61B17/0218 , A61B2017/306 , A61B17/3478 , A61B2018/00005 , A61B2018/00011 , A61B2018/00017 , A61B2018/00029 , A61B2018/00041 , A61B2018/0022 , A61B2018/00255 , A61B2018/00285 , A61B2018/00291 , A61B2018/00494 , A61B2018/00559 , A61B2018/00577 , A61B2018/00642 , A61B2018/00672 , A61B2018/00678 , A61B2018/00744 , A61B2018/00791 , A61B2018/00809 , A61B2018/00815 , A61B2018/00821 , A61B2018/00839 , A61B2018/00863 , A61B2018/00875 , A61B2018/00982 , A61B2018/0212 , A61B2018/046 , A61B18/06 , A61B2018/1861 , A61B18/24 , A61B2090/3908 , A61B2090/3933 , A61B2090/395 , A61B2218/002 , A61B2505/05 , A61B2560/0431 , A61B2562/227 , A61M25/0082 , A61M2210/1053 , A61M2210/1057 , A61M2210/1071 , A61M2210/1408 , A61N7/022
Abstract: A method for performing a medical procedure in an intestine of a patient is provided. The method comprises providing a system comprising: a catheter for insertion into the intestine, the catheter comprising: an elongate shaft comprising a distal portion; and a functional assembly positioned on the shaft distal portion and comprising at least one treatment element. The catheter is introduced into the patient, and target tissue is treated with the at least one treatment element. The target tissue comprises mucosal tissue of the small intestine, and the medical procedure can be configured to treat polycystic ovarian syndrome (PCOS).
-
Patent Agency Ranking
公开(公告)号：US12096978B2
公开(公告)日：2024-09-24
申请号：US17931379
申请日：2022-09-12
Inventor： Paul Coates
IPC: A61B18/14 , A61B18/02 , A61B18/12 , A61F7/12 , A61N1/05 , A61N1/36 , A61N1/40 , A61N7/02 , A61B18/00 , A61B18/06 , A61N7/00
CPC classification number: A61B18/1492 , A61B18/02 , A61B18/1206 , A61F7/12 , A61N1/0551 , A61N1/36017 , A61N1/36031 , A61N1/40 , A61N7/02 , A61N7/022 , A61B2018/00023 , A61B2018/00029 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00642 , A61B2018/00702 , A61B2018/00714 , A61B2018/00744 , A61B2018/00779 , A61B2018/00791 , A61B2018/00875 , A61B2018/00982 , A61B2018/0212 , A61B18/06 , A61B2018/1407 , A61B2018/1435 , A61B2018/1467 , A61B2218/002 , A61F2007/126 , A61N1/0558 , A61N2007/003
Abstract: Neuromodulation catheter systems with controlled irrigation capabilities and methods for using such systems are disclosed herein. One such method includes, for example, positioning an irrigated neuromodulation catheter at a treatment site within a renal blood vessel of a human patient, delivering neuromodulation energy at the treatment site, and delivering irrigation fluid to the treatment site having characteristics coordinated with the delivered energy. The characteristics can be adjusted to maintain an energy delivery element and/or tissue of the blood vessel at a constant temperature as power is increased. The method can further include monitoring at least one parameter of the tissue and/or of the energy delivery element, and adjusting the neuromodulation energy and/or the characteristics of the irrigation fluid if the at least one parameter falls outside of a treatment range of values.
-
公开(公告)号：US12096968B2
公开(公告)日：2024-09-24
申请号：US16338095
申请日：2017-06-26
Applicant: SUZHOU SINUS MEDICAL TECHNOLOGIES CO., LTD
Inventor： Xingpeng Liu , Jun Mao , Mingdong Zhang
CPC classification number: A61B18/06 , A61M25/007 , A61M25/0074 , A61B2017/00539 , A61B2017/00544 , A61B2017/2926 , A61B2017/3409 , A61B17/3478 , A61B2018/00351 , A61B2018/00577 , A61M2025/0087
Abstract: The disclosure relates to a chemical ablation apparatus for treating arrhythmia. The apparatus includes a clamp body, a clamp head consisting of a pair of clamp jaws, a needle head assembly, a needle head extension and retraction control assembly, pipeline components, and an electrocardiographic mapping component. The chemical ablation apparatus can control needle heads to extend out of or retract into the clamp head by means of the needle head extension and retraction control assembly. A chemical ablation reagent may be injected to a cardiac muscle tissue to conveniently achieve complete ablation of the cardiac muscle tissue by applying a chemical ablation method. The ablation effect can be verified by an electrocardiographic mapping system, to increase the success rate and lower the difficulty level of arrhythmia ablation operations, while also reducing the manufacturing cost of ablation apparatus and corollary equipment thereof, and decreasing expenses for atrial fibrillation surgical operations.
-
公开(公告)号：US20240277976A1
公开(公告)日：2024-08-22
申请号：US18644498
申请日：2024-04-24
Applicant: Lixiao Wang , Neurotronic, Inc.
Inventor： Lixiao Wang , John J. Chen , Yongxing Zhang
CPC classification number: A61M25/1002 , A61B18/06 , A61K31/045 , A61M5/007 , A61M5/142 , A61M5/172 , A61M25/1011 , A61M29/02 , A61B2018/00577 , A61M2025/105 , A61M2025/1052 , A61M2202/02
Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US12036148B2
公开(公告)日：2024-07-16
申请号：US18045396
申请日：2022-10-10
Applicant: Candesant Biomedical, Inc.
Inventor： Jacob M. Waugh , Christopher Elkins , Hyop Rhee
CPC classification number: A61F7/03 , A61B18/06 , A61F7/034 , A61F7/12 , A61F2007/0003 , A61F2007/0006 , A61F2007/0019 , A61F2007/0022 , A61F2007/0024 , A61F2007/0036 , A61F2007/0047
Abstract: A device comprising a heat-generating component that comprises an alkali metal is provided. The alkali metal in the presence of water at a point of contact of the device undergoes an exothermic reaction to generate heat in situ. The amount of heat generated is proportional to and/or limited by the amount (or moles) of water at the point of contact, and the heat generated is sufficient to achieve an increase in temperature at the point of contact to achieve a therapeutic or beneficial result. In one embodiment, the device is used for reducing sweat production in a subject suffering from excessive sweating or hyperhidrosis. In other embodiments, the device is used to substantially sterilize a surface or render a surface substantially aseptic.
-
公开(公告)号：US20240206939A1
公开(公告)日：2024-06-27
申请号：US18595873
申请日：2024-03-05
Inventor： Bobak Robert Azamian , Jonathan Allen Coe , Scott Bradley Vafai
IPC: A61B18/02 , A61B17/00 , A61B17/32 , A61B18/00 , A61B18/04 , A61B18/06 , A61B18/14 , A61B18/18 , A61B18/20 , A61B18/24 , A61K9/00 , A61K31/045 , A61K31/05 , A61K31/395 , A61K33/30 , A61K45/06 , A61M5/14 , A61N1/05 , A61N5/00 , A61N7/00 , A61N7/02
CPC classification number: A61B18/02 , A61B17/00 , A61B17/00234 , A61B17/32 , A61B18/04 , A61B18/06 , A61B18/1492 , A61B18/1815 , A61B18/20 , A61B18/24 , A61K9/0019 , A61K31/045 , A61K31/05 , A61K31/395 , A61K33/30 , A61K45/06 , A61M5/14 , A61N1/0551 , A61N5/00 , A61N7/00 , A61B2017/00318 , A61B2017/320069 , A61B2017/32007 , A61B2018/00023 , A61B2018/00214 , A61B2018/0022 , A61B2018/00404 , A61B2018/00434 , A61B2018/00529 , A61B2018/00577 , A61B2018/00732 , A61B2018/00791 , A61B2018/00839 , A61B2018/00994 , A61B2018/0212 , A61B2018/048 , A61B2018/1861 , A61N7/022
Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
-
-
-
-
-
-
-
-
-
Search Results
496
records
(took 0.031 seconds)
